Browse Articles
Discover research articles across all indexed journals
Angiography-Based Physiology to Guide Coronary Revascularization
Miniaturized wireless bioelectronics for electrically driven biohybrid robots
Abstract Although biohybrid robots offer the potential for soft, adaptive actuation by harnessing living muscle, practical operation in cell culture environments is often limited by the requirement of immersed leads or cumbersome stimulation equipment. Here, we present a thin, miniaturized, wireless bioelectronic stimulator that can electrically drive biohybrid robots while maintaining stability in aqueous cell culture media. Built on a 50-µm liquid crystal polymer (LCP) substrate, the device integrates a planar receiving coil, interconnects, a diode-based rectifier, and a tank capacitor. This enables the device to convert an approximately 4.9-MHz radio-frequency (RF) input into pulsed direct current (DC), which is delivered through integrated stimulation electrodes. The stimulator has a footprint of ~ 32 mm² and a total thickness and mass of ~ 100 μm and ~ 7 mg, respectively. We integrated the stimulator with a nanopatterned carbon nanotube (CNT)/gelatin hydrogel fin seeded with human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) to generate propulsion through fin flapping. By optimizing the thickness of the polydimethylsiloxane (PDMS) encapsulation layer, the density was tuned, and the robot remained freely floating and retained shape integrity during operation. This produced autonomous forward locomotion of 74.8 ± 16.4 μm s − 1 . The stimulator generated distance-dependent output voltage pulses and enabled external pacing/modulation under the tested conditions, without a marked loss of cardiomyocyte attachment or α-actinin-positive sarcomeric organization. Together, these results provide a proof-of-concept compact, media-compatible, wireless bioelectronic interface toward closed-system biohybrid robotics.
What’s the human cost of US research turmoil? A new film finds out
The Invisible Load of Cognitive Symptoms
Courtship vocalizations of male mice do not always attract females
Abstract Male house mice ( Mus musculus ) emit ultrasonic vocalizations (USVs) during courtship and mating, which influence their copulatory success. Several studies have found that playbacks of male USVs attract females, though this response may depend on the presence of male scent, and one study suggested that females are more attracted to complex than simple USV types. We conducted three playback experiments with wild-derived female house mice to test these predictions. None of our results met our expectations: First, females were not more attracted to sequences of complex versus simple USVs. Second, females were also not more attracted to these syllables when compared to silence. Third, females showed no attraction towards more natural sequences containing simple and complex USVs compared to silence, even in the presence of male scent. Thus, we found no evidence that wild-derived female mice show approach behavior towards male USVs, regardless of their complexity or exposure to male olfactory stimuli. These findings raise questions about the repeatability and generalizability of playback studies in house mice and highlight the need for more studies aimed at determining the types of vocalizations and contexts under which mice do and do not show attraction or other responses to USVs.
Physiological Assessment of Coronary Artery Disease
High prevalence and phylogenetic diversity of coronaviruses in insectivorous cave-dwelling bats in the Republic of the Congo
Hypertension Control in Low-Income Patients
Assessing the cross-region knowledge transfer capability of selected deep learning building vectorization methods in the context of available training datasets
Cat Scratch Disease
An approach to fault detection and dynamic fault tolerance for flush air data sensing system with multiple faults
The Daily Grind
Estimation of myocardial and blood gadolinium concentrations from T1 mapping via pharmacokinetic modeling: influence of elastic deformation registration
Declarations of Independence — Physicians and the U.S. Body Politic, 1776–2026
Baseline assessment of sedimentary heavy metals and ecological risks in the high-siltation Gorai River, Bangladesh
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma
Application of ephrin-B2 loaded glycol chitosan-silk fibroin hydrogel in the treatment of diabetic refractory wounds
Abstract Diabetic skin ulcers are a major cause of disability, yet effective treatments remain limited due to microvascular dysfunction. This study investigated the effects of a glycol chitosan-silk fibroin hydrogel loaded with Ephrin-B2 (GCS-SF-B2 Gel) on the healing of full-thickness skin wounds in a diabetic mouse model. We prepared the hydrogel by mixing glycol chitosan and silk fibroin solutions, followed by lyophilization and adsorption of Ephrin-B2. The GCS-SF-B2 Gel exhibited a porous structure with a swelling capacity of up to 1600% and a moisturizing duration of up to 12 h. In vitro assays demonstrated that the hydrogel significantly promoted the proliferation and migration of NIH 3T3 cells. In a diabetic mouse model with full-thickness skin defects, the GCS-SF-B2 Gel demonstrated superior therapeutic efficacy compared to control, evidenced by macroscopic healing, increased fibroblast accumulation, improved collagen deposition, and significant angiogenesis at the wound site. These findings suggest that GCS-SF-B2 Gel is a promising candidate for promoting the healing of refractory diabetic wounds.
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1
Abstract Intravenous administration of anti-CTLA4 with anti-PD1 provides durable tumour responses but causes severe treatment-related adverse events in patients with cancer 1 . Intratumoural administration at lower doses but high local concentrations could enhance antitumour efficacy while minimizing systemic exposure and toxicity. Here we report the randomized multicentre phase 1b NIVIPIT trial (ClinicalTrials.gov: NCT02857569 ), which enrolled 61 patients with untreated metastatic melanoma, randomly assigned 2:1 to receive intravenous nivolumab (anti-PD1; 1 mg kg −1 ) combined with either intratumoural ipilimumab (anti-CTLA4; 0.3 mg kg −1 ) or intravenous ipilimumab (3 mg kg −1 ). The primary end-point was met with significantly lower incidence of grade 3 or 4 treatment-related adverse events at 6 months in the intratumoural versus intravenous arm (22.6% versus 57.1%), equivalent to anti-PD1 monotherapy. RECIST (response evaluation criteria in solid tumours) best objective response rate reached 65.7% for anti-CTLA4 injected lesions and 50% for uninjected lesions, confirming the relationship between intratumoural exposure to anti-CTLA4 and efficacy. Baseline tumour immune profiling revealed that protumoural activated regulatory T (T reg ) cells and M2 macrophages predict durable clinical benefit, regardless of the anti-CTLA4 administration route. A decrease in activated intratumoural T reg cells occurred only in patients who showed durable clinical benefit, who also presented high intratumoural Fcγ receptor (FcγR) expression. Our results provide a rationale for intratumoural anti-CTLA4 strategies in oligometastatic and early-stage cancers and indicate that high intratumoural activated T reg cell and FcγR + M2 macrophage numbers are prerequisites for efficacy of combined anti-CTLA4 and anti-PD1.